Pricing

Akero

0 followers

‌

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being eva... Read more

Industries

Biotechnology, Education

Headquarters

South San Francisco, United States

Employees

Links

Org chart

President & CEO

Andrew Cheng

Collapse

COO & Co Founder

Chief Scientific Officer & Co-Founder

CFO & Head of Corporate Development

Chief Development Officer

Dominick Villani

VP & Quality

Brittany de Temple

VP of Development Operations

VP of Regulatory Affairs

SVP, Commercial Strategy

EVP And Chief Development Officer

Vice President Legal

Teams

Clinical Research and Development

12 members

Financial and Accounting Team

7 members

Development Team

6 members

Leadership Team

6 members

Quality Control Team

3 members

Offices

Similar companies

Kyverna Therapeutics

7 followers

Generate Biomedicines

3 followers

Kriya Therapeutics

1 follower

Gameto

4 followers

Synthekine

3 followers

Tango Therapeutics

2 followers

Caribou Biosciences

2 followers

Vera Therapeutics

2 followers

Neogene Therapeutics

2 followers

Day One Biopharmaceuticals

1 follower

Apogee Therapeutics

1 follower

Explore companies